Copper Peptides / Brand Reviews
NIOD CAIS3 Review: Premium Copper, Proprietary Mystique
NIOD CAIS3 is one of the most serious copper peptide formulas you can buy: 1% GHK-Cu paired 1:1 with 1% GHK, $93 for 30 ml as of August 2026. The catch is verifiability. Its supporting studies are in-house, unpublished and uncited, so the impressive claims ultimately rest on trust in the brand.
NIOD is Deciem's advanced line, the sibling brand that speaks in acronyms and assumes you did the reading. CAIS3 is its flagship copper serum, and it is a genuinely sophisticated product wrapped in the most opaque marketing in the category. This review takes both halves seriously: the formulation substance that justifies the reputation, and the proprietary mystique that makes the $93 question harder to answer than it should be.
What's in This Review
01 /What CAIS3 is
Copper Amino Isolate Serum 3 1:1, mercifully shortened to CAIS3, is the third generation of NIOD's copper peptide flagship and the most copper-committed product in the Deciem family. As of August 2026 it sells for $93 for 30 ml on niod.com, with a 15 ml size for the curious. That price makes it the most expensive serum in our copper review series by a wide margin.
The formula's stated centerpiece: 1% copper peptides (GHK-Cu) alongside 1% copper-free GHK peptide, the 1:1 ratio the name advertises. That is a fully disclosed, unusually high peptide load for this category, and it is worth pausing on: whatever else one says about NIOD's marketing, the brand does print its concentrations. GHK-Cu itself is the most-studied molecule in cosmetic copper, with decades of laboratory work on collagen-related pathways and skin renewal signaling.[1][2]
02 /The 1:1 ratio claim, decoded
The 1:1 concept is the most interesting formulation idea in the category. GHK-Cu is the tripeptide GHK bound to a copper ion; copper-free GHK is the same peptide without the metal. Both forms appear in the research literature, and the peptide's affinity for copper means the two forms interact dynamically in solution and in skin.[2][3] NIOD's bet is that supplying both, in equal measure, covers more ground than the copper-bound form alone.
Is the bet right? Nobody outside NIOD knows. No independent, published study has compared a 1:1 GHK-Cu and GHK pairing against a standard GHK-Cu serum on real faces. The idea is chemically literate and plausible, and it is also, as of August 2026, unverified in the public record. That dual truth is the honest summary of most of what makes CAIS3 distinctive, and it is why our copper peptide percentage guide treats ratio claims as a separate question from concentration claims: the first is proprietary territory, the second you can at least compare across labels.
03 /What NIOD gets right
A copper-first formula with real substance
CAIS3 is not a marketing serum with a whisper of peptide. A disclosed 1% GHK-Cu plus 1% GHK, two full percent of tripeptide between them, is the heaviest disclosed peptide load we know of in the mainstream category, and the surrounding formula reflects Deciem's genuine formulation depth. Texture, finish and packaging refinement across three product generations show a brand that iterates on substance, not just labels.
Disclosure where it counts most
The concentration is printed, plainly. In a category where premium pricing often hides behind "contains copper peptides," NIOD states its numbers, which makes the per-milligram value math possible. Compare that with the mystery-dose products flagged in our guide to spotting an underdosed copper peptide serum and the difference is stark: CAIS3's premium buys visible substance, not secrecy.
It tests at all
The product page describes 4, 8 and 12 week user testing on panels of 31 to 32 people using the serum twice daily, reporting smoother feel and a more even, firmer look over time. Plenty of brands run no testing whatsoever. Running structured panels, even in-house ones, is more diligence than much of the industry bothers with, and the reported findings stay in believable appearance territory rather than promising transformations.
04 /The verifiability problem
Here is the other half. Those studies are NIOD's own. They are not peer-reviewed, not published anywhere a third party can inspect, and the page links no citations to the wider literature. Panel sizes of 31 and 32 are small, the methodology is not public, and phrases summarizing the results cannot be checked against baselines, controls or statistics. In short: every distinctive claim CAIS3 makes, from the 1:1 rationale to the week-by-week results, rests on trusting the brand.
To be scrupulously fair, this is normal cosmetics practice, and nothing about NIOD suggests bad faith. The published scientific record on topical peptides is itself modest once you step past mechanism into strong human evidence, a limitation reviewers have noted for the category as a whole.[4] What does exist in public for the copper tripeptide, mechanism studies and in vitro penetration mapping, is the shared foundation every brand builds on, NIOD included.[5] But normal is not the standard a $93 serum invites. At triple the category's typical price, "trust us" carries more weight than it should, and a brand this scientifically fluent choosing not to publish or cite is a choice worth naming.
CAIS3's distinctive claims are plausible, coherent and entirely unverifiable from outside the company. You are not being deceived; you are being asked to take the brand's word, at a premium.
05 /Translating the jargon
NIOD's register is famously dense, so here is the plain-English version of the vocabulary a CAIS3 shopper meets.
- Copper Amino Isolate: copper peptides, presented formally. The "isolate" framing signals purity of the peptide fraction, not a different molecule.
- 1:1: equal parts copper-bound GHK-Cu and copper-free GHK, one percent each, as covered above.
- Generation 3: the third revision of the formula; earlier versions used different peptide configurations. Iteration is real, though no public data compares the generations.
- Twice-daily protocol: the usage pattern behind the brand's panel results. Any copper serum this concentrated deserves a slower introduction than that for new users.
The science-adjacent language mostly maps to real chemistry, which separates NIOD from brands that use jargon as decoration. The cost is evaluability: a shopper without a chemistry background cannot easily tell which phrases carry substance and which carry style, and with no linked references there is no trail to follow. Skin-facing practicalities are simpler: a 1% copper serum still obeys ordinary routine chemistry, so keep it clear of direct acids, direct vitamin C and retinoids in the same session, per our complete compatibility guide, and introduce it gradually as described in our side effects and safety guide.
06 /Price, value, and how it compares
Now the math, which lands somewhere surprising. At a disclosed 1%, a 30 ml bottle carries roughly 300 mg of GHK-Cu, plus another 300 mg of copper-free GHK. That is about 31 cents per milligram of GHK-Cu, which makes CAIS3, despite the $93 sticker, one of the cheaper serums in the category per milligram of disclosed copper peptide. The premium buys concentration, not just branding, and honesty requires saying so plainly.
| Claim | Status | How to check |
|---|---|---|
| $93 for 30 ml | Verifiable | niod.com, as of August 2026 |
| 1% GHK-Cu + 1% GHK disclosed | Verifiable as a label claim | Product page and packaging |
| Ingredient list | Verifiable | Published INCI |
| 4, 8, 12 week panel results | Trust required | In-house, unpublished, no methodology shared |
| 1:1 ratio outperforms standard GHK-Cu | Trust required | No independent comparison exists |
| Better than cheaper serums in the mirror | Unknown | No head-to-head data at any price |
For scale across the disclosed-dose field, our own MAXXING Glow discloses 0.2% GHK-Cu at $49.99 for 50 ml, a deliberately gentler daily-driver dose you can compare milligram for milligram against anything reviewed here. If maximum disclosed peptide load is your criterion, CAIS3 genuinely owns that lane; the rest of the category, ours included, competes on comfort, simplicity and price rather than peptide load.
07 /The honest verdict
CAIS3 earns its reputation as the serious enthusiast's copper serum. The disclosed peptide load is the heaviest we know of in the mainstream category, the per-milligram value is unexpectedly strong, the formulation lineage is real, and the brand's claims, while unverifiable, stay within believable appearance language rather than fantasy. As a piece of formulation ambition, it is easy to respect.
What $93 does not buy is proof. The in-house panels are unpublished, the 1:1 rationale is untested outside the company, and the dense proprietary language, whatever its chemical literacy, makes independent evaluation harder rather than easier. Shoppers who want verifiable reasoning per dollar will find that gap harder to accept at this price than at $22 or $32.
Buy CAIS3 if you want the heaviest disclosed copper peptide load on the market and you are comfortable taking the brand's research on faith. If verifiability per dollar is your metric, the honest labels further down the price ladder answer more questions.
08 /Frequently asked questions
CAIS3, short for Copper Amino Isolate Serum 3 1:1, is the third generation of NIOD's flagship copper peptide serum. It pairs 1% GHK-Cu with 1% copper-free GHK, the 1:1 in the name. As of August 2026 the 30 ml bottle costs $93 on niod.com, with a smaller 15 ml size also sold.
It is the claimed ratio of copper-bound GHK-Cu to copper-free GHK peptide, at 1% each. The idea is to supply the peptide in both forms. Both molecules appear in the published research literature, but no independent study has tested whether this specific ratio outperforms a standard GHK-Cu serum.
No. The product page describes in-house testing panels of 31 people at 4 and 8 weeks and 32 people at 12 weeks, using the serum twice daily. Those results are not peer-reviewed, the methodology is not public, and the page links no citations, so the claims rest on the brand's own word rather than verifiable data.
If you want one of the heaviest disclosed peptide loads in a mainstream serum, CAIS3 delivers real substance: the per-milligram math is surprisingly competitive because the dose is high. If you want claims you can independently verify before spending, the unpublished in-house testing may bother you. Both reactions are reasonable.
It is the deep end of the disclosed range. Higher concentrations are not automatically better and can feel like more for sensitive skin, so first-time users often do better starting lower, or starting CAIS3 slowly at two to three evenings per week with a patch test first. Comfort, not maximum strength, should drive the choice.
Three things: a higher disclosed concentration than the budget end of the category, the copper-free GHK pairing that nobody else runs, and NIOD's textural and formulation refinement. What it does not offer is independently verifiable evidence that those differences change what you see in the mirror; that question remains open at every price.
References
- Maquart FX, Pickart L, Laurent M, et al. "Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+." FEBS Lett. 1988;238(2):343-346. PubMed
- Pickart L, Vasquez-Soltero JM, Margolina A. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." Biomed Res Int. 2015;2015:648108. PubMed
- Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci. 2018;19(7):1987. PubMed
- Gorouhi F, Maibach HI. "Role of topical peptides in preventing or treating aged skin." Int J Cosmet Sci. 2009;31(5):327-345. PubMed
- Hostynek JJ, Dreher F, Maibach HI. "Human skin penetration of a copper tripeptide in vitro as a function of skin layer." Inflamm Res. 2011;60(1):79-86. PubMed